Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseLife at Premier By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Product Development Navigating Regulatory Pathways for Digital Therapeutics By Premier Research July 27, 2022 Clinical ResearchPhase 1 - Phase 4 Addressing the Top 7 Challenges in Decentralized Dermatology Trials By Stacy Weil July 13, 2022 Clinical ResearchPhase 1 - Phase 4 Full Service or FSP? How to Choose the Right Model for Your Study By Cheryl Silva June 28, 2022 Clinical ResearchPhase 1 - Phase 4 7 Tips for Designing and Operationalizing Rare Disease Natural History Studies By Kris O'Brien June 27, 2022 Clinical ResearchPhase 1 - Phase 4 How to Use Patient Registries and Natural History Studies in Rare Disease Development By Kris O'Brien June 17, 2022 Clinical ResearchPhase 1 - Phase 4 Considerations for Clinical Studies in Contraception By Clint Dart June 2, 2022 Previous 1 …9 10 11 12 13 … 57 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today